Comparison of Radiation Pneumonitis in Lung Cancer Patients Treated with HT versus IMRT and Circulating Lymphocyte Subsets as Predicting Risk Factors
Authors:
- Xin ZhangXZXin Zhang
- Dingyi YangDYDingyi Yang
- Yong JiangYJYong Jiang
- Luo HuangLHLuo Huang
- Can WangCWCan Wang
- Dan TaoDTDan Tao
- Xianfeng LiuXLXianfeng Liu
- Yongyang LeiYLYongyang Lei
- Yongzhong WuYWYongzhong Wu
- Wei ZhouWZWei Zhou
Open Access
- 1 August 2021
- journal article
- research article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 14, 4205-4215
Abstract
Purpose: We sought to compare the symptomatic radiation pneumonitis (RP) in lung cancer patients treated with helical tomotherapy (HT) versus intensity-modulated radiotherapy (IMRT), and examine the predictive value of circulating lymphocyte subsets affecting the occurrence of RP. Patients and Methods: Circulating lymphocyte subsets, clinical characteristics, dosimetric parameters and pulmonary function were collected from 130 lung cancer patients treated with HT (n = 53) or IMRT (n = 77) from 2016 through 2020. Symptomatic RP was compared between groups. Binary logistic regression was used to identify predictors of RP. Results: The IMRT group had larger planning target volume (319.9 vs 240.8 cc, P = 0.041); more ECOG performance status 0– 1 (96.1% vs 79.2%, P = 0.002); more stage III–IV disease (94.8% vs 37.6%, P = 0.028); and more combined systemic therapy (85.7% vs 69.8%, P = 0.022). Grade ≥ 2 RP were comparable between IMRT and HT groups (16.9% vs 15.1%, P = 0.785). For stage III–IV disease, IMRT was associated with lower lung V10 (31.9% vs 35.8%, P = 0.047) and lower incidence of grade 5 RP (0% vs 9.1%, P = 0.018). All lymphocyte subsets reduced after radiotherapy. The decrease degree of total T cell count and CD4+ T cell count were larger after IMRT than HT (P = 0.043, P = 0.021). In univariate analysis, the smoking status, lower baseline FEV1, and higher total T cell count, higher CD8+ T cell count, lower total B cell count, lower CD4+/CD8+ ratio after radiotherapy were associated with the development of grade ≥ 2 RP. The higher CD8+T cell count after radiotherapy was the only risk factor associated with grade ≥ 2 RP in multivariable analysis (OR 1.003; 95% CI: 1.000– 1.005; P = 0.044). Conclusion: IMRT was associated with lower lung V10 and less grade 5 RP than HT for stage III–IV lung cancer. Higher CD8+ T cell count after radiotherapy was associated with an increased risk of RP. HT may better preserve total T cell and CD4+ T cell than IMRT.Keywords
This publication has 31 references indexed in Scilit:
- Predictive Factors for Radiation Pneumonitis in Lung Cancer Treated with Helical TomotherapyCancer Research and Treatment, 2013
- Significance of low-dose radiation distribution in development of radiation pneumonitis after helical-tomotherapy-based hypofractionated radiotherapy for pulmonary metastasesJournal of Radiation Research, 2013
- Poor Baseline Pulmonary Function May Not Increase the Risk of Radiation-Induced Lung ToxicityInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Change in Diffusing Capacity After Radiation as an Objective Measure for Grading Radiation Pneumonitis in Patients Treated for Non-Small-Cell Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Treatment-Related Pneumonitis and Acute Esophagitis in Non–Small-Cell Lung Cancer Patients Treated With Chemotherapy and Helical TomotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Use of Normal Tissue Complication Probability Models in the ClinicInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLCRadiotherapy and Oncology, 2008
- CD4 and CD8 T-Lymphocyte Apoptosis Can Predict Radiation-Induced Late Toxicity: A Prospective Study in 399 PatientsClinical Cancer Research, 2005
- TomotherapySeminars in Radiation Oncology, 1999
- Tomotherapy: A new concept for the delivery of dynamic conformal radiotherapyMedical Physics, 1993